POLITICS● LOWSep 18 · Sep 18, 2026, 11:08 AM
Trump administration is said to weigh allowing most pharma licensing deals with China
Seeking Alpha Tech · global
The Trump administration is reportedly considering a policy change to allow most pharmaceutical licensing deals with China. This potential shift impacts trade relations and the pharmaceutical industry.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Politics
POLITICS15m agoLawyer or just a jurist? New White House spokesperson immediately under fireNOS BuitenlandPOLITICS20m ago2027: Radda chairs Tinubu campaign council in Katsina, minister named DGPremium TimesPOLITICS22m agoFT: U.S. proposed unfreezing some Russian assets and placing them under Washington’s control; Europe rejected the planMeduza [en]POLITICS28m agoTaiwan president urges Micron, unions to resolve bonus disputeSeeking Alpha Tech